Cancer patients are at high risk for venous thromboembolism (VTE) and cancer-associated VTE is a major health problem due to its effects on deterioration of disease prognosis, increased treatment costs and delayed cancer ...

Febrile neutropenia (FN) is the most important dose-limiting side effect of chemotherapy, occurring in approximately 19% of cancer patients. This study aimed to evaluate the risk factors for development of FN among cancer ...